Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Bacillus Calmette-Guerin is the most effective therapy for nonmuscle invasive bladder cancer. Recently to calculate the risks of recurrence and progression based on data from 7 European Organisation for Research and Treatment of Cancer trials a scoring system was reported. However, in that series only 171 patients were treated with bacillus Calmette-Guerin. We developed a risk stratification model to provide accurate estimates of recurrence and progression probability after bacillus Calmette-Guerin.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Urol.

Title: The Journal of urology

Publisher: Elsevier BV

ISSN (Electronic): 1527-3792

ISSN (Print): 0022-5347

Publication date (Electronic): Nov 2009

Volume: 182

Issue: 5

Affiliations

[1 ] Department of Urology, Hospital Central of Asturias, University of Oviedo, Oviedo, Spain. jmfernandezgomez@telefonica.net

Article

Publisher Item ID: S0022-5347(09)01740-6

DOI: 10.1016/j.juro.2009.07.016

PubMed ID: 19758621

SO-VID: 18a14807-3152-43d6-829a-48a694bfcc45

History

Data availability:

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.